1. Home
  2. ADMA vs SIM Comparison

ADMA vs SIM Comparison

Compare ADMA & SIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADMA
  • SIM
  • Stock Information
  • Founded
  • ADMA 2004
  • SIM 1969
  • Country
  • ADMA United States
  • SIM Mexico
  • Employees
  • ADMA N/A
  • SIM N/A
  • Industry
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • SIM Steel/Iron Ore
  • Sector
  • ADMA Health Care
  • SIM Industrials
  • Exchange
  • ADMA Nasdaq
  • SIM Nasdaq
  • Market Cap
  • ADMA 5.1B
  • SIM 4.2B
  • IPO Year
  • ADMA N/A
  • SIM 1993
  • Fundamental
  • Price
  • ADMA $18.51
  • SIM $28.23
  • Analyst Decision
  • ADMA Strong Buy
  • SIM
  • Analyst Count
  • ADMA 3
  • SIM 0
  • Target Price
  • ADMA $27.67
  • SIM N/A
  • AVG Volume (30 Days)
  • ADMA 3.3M
  • SIM 1.8K
  • Earning Date
  • ADMA 08-07-2025
  • SIM 07-21-2025
  • Dividend Yield
  • ADMA N/A
  • SIM N/A
  • EPS Growth
  • ADMA N/A
  • SIM 122.92
  • EPS
  • ADMA 0.84
  • SIM 3.34
  • Revenue
  • ADMA $459,381,000.00
  • SIM $1,641,713,837.00
  • Revenue This Year
  • ADMA $23.35
  • SIM N/A
  • Revenue Next Year
  • ADMA $27.67
  • SIM N/A
  • P/E Ratio
  • ADMA $22.16
  • SIM $8.46
  • Revenue Growth
  • ADMA 62.23
  • SIM N/A
  • 52 Week Low
  • ADMA $10.21
  • SIM $22.15
  • 52 Week High
  • ADMA $25.67
  • SIM $31.00
  • Technical
  • Relative Strength Index (RSI)
  • ADMA 46.05
  • SIM 68.26
  • Support Level
  • ADMA $17.90
  • SIM $27.94
  • Resistance Level
  • ADMA $18.69
  • SIM $29.60
  • Average True Range (ATR)
  • ADMA 0.62
  • SIM 0.23
  • MACD
  • ADMA 0.10
  • SIM 0.16
  • Stochastic Oscillator
  • ADMA 74.12
  • SIM 59.35

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About SIM Grupo Simec S.A.B. de C.V.

Grupo Simec SAB de CV is a diversified producer, processor and distributor of SBQ steel and structural steel products with production and commercial operations. The group's SBQ products are used across a range of engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment. Its structural steel products are used in the non-residential construction market and other construction applications. Its segments are Mexico, Brazil, and the United States. The maximum of its sales is from the Mexico segment.

Share on Social Networks: